GSK Investigational Site

Passo Fundo, Rio Grande do Sul 99010-080

0 studies enrolling now · 4 studies all time

What they study most

Anaemia, Aspergillosis, Allergic Bronchopulmonary, Skin Infections, Bacterial

Studies at this site

• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) — Completed
• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) — Completed
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD) — Completed
• Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) — Completed